New AHA guidance targets obesity-related hypertensionSeptember 22, 2021HypertensionHeart FailureDiabetes
FDA approves Abbott’s Portico valve for TAVRSeptember 22, 2021Interventional Cardiology & SurgeryHeart Failure
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinitionSeptember 20, 2021Heart FailureDiabetes
Texts boost activity, quality of life in patients with heart failure and diabetesSeptember 16, 2021DiabetesHeart Failure
Weight-loss surgery linked to fewer cardiovascular events, more so with RYGBSeptember 15, 2021Acute Coronary SyndromesStrokeCAD & AtherosclerosisHeart FailureDiabetesLipid DisordersHypertension
PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEFSeptember 14, 2021Heart FailureDiabetesLipid Disorders
Are ESC’s new heart failure guidelines already outdated?September 14, 2021Heart FailureHypertensionDiabetes
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEFAugust 31, 2021Heart FailureDiabetesLipid Disorders
Although inconclusive, CV safety study of cancer therapy attracts attentionAugust 30, 2021Acute Coronary SyndromesCAD & AtherosclerosisStrokeHeart Failure
APAF-CRT: ‘Ablate and pace’ cuts mortality in narrow-QRS HF, permanent AFibAugust 28, 2021Arrhythmias & EPHeart FailureInterventional Cardiology & Surgery
FIDELITY: Finerenone benefits patients with T2D across CKD spectrumAugust 28, 2021Heart FailureDiabetes
Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HFAugust 27, 2021Arrhythmias & EPHeart FailureDiabetes
ICMs detect serious arrhythmias in high-risk post-MI patients: SMART-MIAugust 27, 2021Arrhythmias & EPAcute Coronary SyndromesHeart Failure
